reglab/housing_qa huggingface dataset:
NJ Rev Stat § 24:21-8 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-8 - Schedule IV.

24:21-8 Schedule IV.  8. Schedule IV. a. Tests. The director shall place a substance in Schedule IV if he finds that the substance: (1) has low potential for abuse relative to the substances listed in Schedule III; (2) has currently accepted medical use in treatment in the United States; and (3) may lead to limited physical dependence or psychological dependence relative to the substances listed in Schedule III. b. The controlled dangerous substances listed in this section are included in Schedule IV. c. Any material, compound, mixture or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system: (1) Barbital (2) Chloral betaine (3) Chloral hydrate (4) Ethchlorovynol (5) Ethinamate (6) Methohexital (7) Meprobamate (8) Methylphenobarbital (9) Paraldehyde (10) Petrichloral (11) Phenobarbital. d. The director may except by rule any compound, mixture, or preparation containing any depressant substance listed in subsection c. from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a depressant effect on the central nervous system. L.1970, c.226, s.8; amended 1971, c.3, s.3; 2007, c.244, s.6.
NJ Rev Stat § 24:21-8.1 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-8.1 - Schedule V.

24:21-8.1 Schedule V.  4. Schedule V. a. Tests. The director shall place a substance in Schedule V if he finds that the substance: (1) has low potential for abuse relative to the substances listed in Schedule IV; (2) has currently accepted medical use in treatment in the United States; and (3) has limited physical dependence or psychological dependence liability relative to the substances listed in Schedule IV. b. The controlled dangerous substances listed in this section are included in Schedule V. c. Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, which also contains one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone: (1) Not more than 200 milligrams of codeine or any of its salts per 100 milliliters or per 100 grams; (2) Not more than 100 milligrams of dihydrocodeine or any of its salts per 100 milliliters or per 100 grams; (3) Not more than 50 milligrams of ethylmorphine or any of its salts per 100 milliliters or per 100 grams; (4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit; (5) Not more than 100 milligrams of opium or any of its salts per 100 milliliters or per 100 grams. L.1971, c.3, s.4; amended 2007, c.244, s.7.
NJ Rev Stat § 24:21-9 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-9 - Rules and regulations.

24:21-9 Rules and regulations.  9. Rules and regulations. The director is authorized to promulgate rules and regulations and to charge reasonable fees relating to the registration and control of the manufacture, distribution, and dispensing of controlled dangerous substances within this State. L.1970, c.226, s.9; amended 2007, c.244, s.8.
NJ Rev Stat § 24:21-10 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-10 - Registration requirements.

24:21-10 Registration requirements.  10. Registration requirements. a. Every person who manufactures, distributes, or dispenses any controlled dangerous substance within this State or who proposes to engage in the manufacture, distribution, or dispensing of any controlled dangerous substance within this State, shall obtain a registration issued by the division in accordance with rules and regulations promulgated by it. b. Persons registered by the director under this act to manufacture, distribute, dispense, or conduct research with controlled dangerous substances may possess, manufacture, distribute, dispense, or conduct research with those substances to the extent authorized by their registration and in conformity with the other provisions of this article. c. The following persons shall not be required to register and may lawfully have under their control or possess controlled dangerous substances under the provisions of P.L.1970, c.226 (C.24:21-1 et seq.), as amended and supplemented; provided, however, that nothing in this section shall be construed as conferring on a person who is not registered or licensed as a practitioner or as a pharmacist any authority, right or privilege that is not granted him by the laws of this State: (1) An agent, or an employee thereof, of any registered manufacturer, distributor, or dispenser of any controlled dangerous substance if such agent is acting in the usual course of his business or employment; (2) A common carrier or warehouseman, or an employee thereof, whose possession of any controlled dangerous substance is in the usual course of his business or employment; (3) An ultimate user or a person in possession of any controlled dangerous substance pursuant to a lawful order of a practitioner or in lawful possession of a Schedule V substance; (4) Peace officers or employees in the performance of their official duties requiring possession or control of controlled dangerous substances; or to temporary incidental possession by employees or agents of persons lawfully entitled to possession, or by persons whose possession is authorized for the purpose of aiding peace officers in performing their official duties. d. The director may, by regulation, waive the requirement for registration of certain manufacturers, distributors, or dispensers if he finds it consistent with the public health and safety. e. A separate registration shall be required at each principal place of business or professional practice where the applicant manufactures, distributes, or dispenses controlled dangerous substances. f. The director is authorized to inspect the establishment of a registrant or applicant for registration in accordance with the rules and regulations promulgated by him. L.1970, c.226, s.10; amended 1971, c.3, s.5; 2007, c.244, s.9.
NJ Rev Stat § 24:21-13 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-13 - Records of registrants.

24:21-13 Records of registrants.  13. Records of registrants. Persons registered to manufacture, distribute, or dispense controlled dangerous substances under P.L.1970, c.226 (C.24:21-1 et seq.), as amended and supplemented, shall keep records and maintain inventories in conformance with the recordkeeping and inventory requirements of federal law and with such additional rules as may be issued by the director. L.1970, c.226, s.13; amended 2007, c.244, s.12.
NJ Rev Stat § 24:21-14 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-14 - Order forms.

24:21-14 Order forms.  14. Order forms. a. Controlled dangerous substances in Schedules I and II shall be distributed only by a registrant, pursuant to an official written order form, clearly identifying it as covering or relating to Schedule I and Schedule II, or either thereof, controlled dangerous substances and bearing the registration number of the registrant. Compliance with federal law respecting order forms shall be deemed compliance with this section. b. A pharmacist, only upon an official written order, may sell to a practitioner in quantities not exceeding one ounce at any one time, aqueous or oleaginous solutions compounded by him of which the content of narcotic drugs or other controlled dangerous substances does not exceed a proportion greater than 20% of the complete solution, to be used for medical purposes. c. An official written order for any controlled dangerous substance in Schedule I or Schedule II shall be signed in triplicate by the person giving said order or by his duly authorized agent. The original and triplicate shall be presented to the person who sells or dispenses the controlled dangerous substance or substances named therein. In the event of the acceptance of such order by said person, except as may be otherwise required by rule, regulation, or order of the director, each party to the transaction shall preserve his copy of such order for a period of two years, in such a way as to be readily accessible for inspection by any public officer or employee engaged in the enforcement of this chapter. d. Use of an official written order in electronic form shall comply with the requirements of State law and regulations. L.1970, c.226, s.14; amended 2007, c.244, s.13.
NJ Rev Stat § 24:21-15 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-15 - Prescriptions.

24:21-15 Prescriptions.  15. Prescriptions. a. Except when dispensed directly in good faith by a practitioner, other than a pharmacist, in the course of his professional practice only, to an ultimate user, no controlled dangerous substance included in Schedule II, which is a prescription drug as defined in section 2 of P.L.2003, c.280 (C.45:14-41), may be dispensed without the written prescription of a practitioner; provided that in emergency situations, as prescribed by the division by regulation, such drug may be dispensed upon oral prescription reduced promptly to writing and filed by the pharmacist, if such oral prescription is authorized by federal law. Prescriptions shall be retained in conformity with the requirements of section 13 of P.L.1970, c.226 (C.24:21-13). No prescription for a Schedule II substance may be refilled. b. Except when dispensed directly in good faith by a practitioner, other than a pharmacist, in the course of his professional practice only, to an ultimate user, no controlled dangerous substance included in Schedules III and IV which is a prescription drug as defined in section 2 of P.L.2003, c.280 (C.45:14-41) may be dispensed without a written or oral prescription. Such prescription may not be filled or refilled more than six months after the date thereof or be refilled more than five times after the date of the prescription, unless renewed by the practitioner. c. No controlled dangerous substance included in Schedule V may be distributed or dispensed other than for a valid and accepted medical purpose. d. A practitioner other than a veterinarian who prescribes a controlled dangerous substance in good faith and in the course of his professional practice may administer the same or cause the same to be administered by a nurse or intern under his direction and supervision. e. A veterinarian who prescribes a controlled dangerous substance not for use by a human being in good faith and in the course of his professional practice may administer the same or cause the same to be administered by an assistant or orderly under his direction and supervision. f. A person who has obtained a controlled dangerous substance from the prescribing practitioner for administration to a patient during the absence of the practitioner shall return to the practitioner any unused portion of the substance when it is no longer required by the patient or when its return is requested by the practitioner. g. Whenever it appears to the division that a drug not considered to be a prescription drug under existing State law should be so considered because of its abuse potential, it shall so advise the New Jersey State Board of Pharmacy and furnish to it all available data relevant thereto. L.1970, c.226, s.15; amended 1971, c.3, s.7; 2007, c.244, s.14.
NJ Rev Stat § 24:21-15.1 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-15.1 - Prescriber to discuss risks of dependence on certain drugs with certain patients.

24:21-15.1 Prescriber to discuss risks of dependence on certain drugs with certain patients.  1. a. A health care professional authorized to issue prescriptions shall, prior to issuing a prescription for an opioid drug which is a Schedule II controlled dangerous substance, discuss with a patient who is under 18 years of age and is an emancipated minor, or with the patient's parent or guardian if the patient is under 18 years of age and is not an emancipated minor, the risks of developing a physical or psychological dependence on the opioid drug and, if the prescriber deems it appropriate, such alternative treatments as may be available. b. A prescriber who engages in a discussion required pursuant to subsection a. of this section shall include a note in the patient's medical record indicating that the discussion took place. c. The discussion required under subsection a. of this section shall not be required prior to issuing a prescription to any patient who is currently receiving hospice care from a licensed hospice. L.2017, c.8, s.1.
NJ Rev Stat § 24:21-15.3 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-15.3 - Rules, regulations.

24:21-15.3 Rules, regulations.  13. a. The Director of the Division of Consumer Affairs, pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), shall adopt rules and regulations to effectuate the purposes of sections 11 and 12 of P.L.2017, c.28 (C.24:21-15.2 and C.45:9-22.19). b. Notwithstanding the provisions of the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.) to the contrary, the Director of the Division of Consumer Affairs may adopt, immediately upon filing with the Office of Administrative Law, and no later than the 90th day after the effective date of this act, such regulations as the director deems necessary to implement any of the provisions of P.L.2017, c.28 (C.17:48-6nn et al.). Regulations adopted pursuant to this subsection shall be effective until the adoption of rules and regulations pursuant to subsection a. of this section, and may be amended, adopted, or readopted by the director in accordance with the requirements of P.L.1968, c.410 (C.52:14B-1 et seq.). L.2017, c.28, s.13.
NJ Rev Stat § 24:21-16 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-16 - Form of label on containers of manufacturers and wholesalers; altering or removing label.

24:21-16 Form of label on containers of manufacturers and wholesalers; altering or removing label.  16. Form of label on containers of manufacturers and wholesalers; altering or removing label. Whenever a manufacturer sells or dispenses a controlled dangerous substance in a package prepared by him, he shall securely affix to each package in which that substance is contained a label showing in legible English the name and address of the vendor and the quantity, kind and form of the substance contained therein. Whenever a wholesaler sells or dispenses a controlled dangerous substance in any package or shipping container other than the package in which received from the manufacturer, he shall securely affix to such package a label showing in legible English his name and address. No person except a phamacist for the purpose of filling a prescription under this act, shall alter, deface or remove any label so affixed by the manufacturer. L.1970,c.226,s.16.
NJ Rev Stat § 24:21-17 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-17 - Form of label to be used by pharmacists; altering or removing label.

24:21-17 Form of label to be used by pharmacists; altering or removing label.  17. Form of label to be used by pharmacists; altering or removing label. Whenever a pharmacist sells or dispenses any controlled dangerous substance on a prescription issued by a practitioner, the pharmacist shall affix to the container in which such drug is sold or dispensed, a label showing the pharmacist's own name, address, and registry number, or the name, address, and registry number of the pharmacist or pharmacy owner for whom the pharmacist is lawfully acting; the name of the patient or, if the patient is an animal, the name of the owner of the animal and the species of the animal; the name of the practitioner by whom the prescription was issued; the brand name or generic name of the drug dispensed unless the prescriber states otherwise on the prescription, such directions as may be stated on the prescription and such directions as may be required by rules or regulations promulgated by the director. In addition, whenever a pharmacist, other than a pharmacist dispensing medication in an institutional pharmacy, as that term is defined in N.J.A.C.13:39-9.2, dispenses an opioid medication on a prescription issued by a practitioner, the pharmacist shall affix to the container in which such opioid medication is sold or dispensed a warning label or sticker describing the risks associated with opioid medications. The New Jersey State Board of Pharmacy shall specify by rule or regulation the location on the medication container where the warning label or sticker shall be affixed, the font and format of any language to be included on the warning label or sticker, and the specific language to be included on the warning label or sticker, which, at a minimum, shall indicate that the medication in the container is an opioid and that opioid medications carry a risk of addiction and overdose. Unless otherwise provided by rules or regulations promulgated by the New Jersey State Board of Pharmacy, the label or sticker shall be red in color with the text printed in black. No person shall alter, deface, or remove any label or sticker so affixed as long as any of the original contents remain. L.1970, c.226, s.17; amended 1979, c.146, s.2; 1986, c.75, s.1; 2007, c.244, s.15; 2019, c.162.
NJ Rev Stat § 24:21-21 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-21 - Prohibited acts C.--Records and order forms of registered manufacturers and distributors--Penalties

24:21-21. Prohibited acts C.--Records and order forms of registered manufacturers and distributors--Penalties  a. It shall be unlawful for any person: (1) Who is subject to the requirements of article 3 of this act to distribute or dispense a controlled dangerous substance in violation of section 14; (2) Who is a registrant, to manufacture, distribute, or dispense a controlled dangerous substance not authorized by his registration; (3) To omit, remove, alter, or obliterate a symbol, label or mark required by Federal or State law; (4) To refuse or fail to make, keep or furnish any record, notification, order form, statement, invoice or information required under this act; (5) To refuse, any entry into any premises or inspection authorized by this act; or, (6) Knowingly to keep or maintain any store, shop, warehouse, dwelling house, building, vehicle, boat, aircraft, or any place whatever, which is resorted to by persons using controlled dangerous substances in violation of this act for the purpose of using such substances, or which is used for the keeping or selling of the same in violation of this act. b. Any person who violates this section shall be subject to a fine of not more than $25,000.00; provided, that if the violation is prosecuted by an accusation or indictment which alleges that the violation was committed knowingly or intentionally, and the trier of fact specifically finds that the violation was committed knowingly or intentionally, such person is guilty of a high misdemeanor and shall be punished by imprisonment for not more than 3 years, or by a fine of not more than $25,000.00, or both. L.1970, c. 226, s. 21.
NJ Rev Stat § 24:21-22 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-22 - Prohibited acts D.--Fraud or misrepresentation by registered manufacturers or distributors--penalties.

24:21-22 Prohibited acts D.--Fraud or misrepresentation by registered manufacturers or distributors--penalties.  Prohibited acts D.--Fraud or misrepresentation by registered manufacturers or distributors--Penalties.  a. It shall be unlawful for any person knowingly or intentionally:  (1) Who is a registrant to distribute a controlled dangerous substance classified in Schedule I or II, in the course of his legitimate business, except pursuant to an order form as required by section 14 of this act;  (2) To use in the course of the manufacture or distribution of a controlled dangerous substance a registration number which is fictitious, revoked, suspended or issued to another person;  (3) (Deleted by amendment, P.L. 1987, c. 106.)  (4) To furnish false or fraudulent material information in, or omit any material information from, any application, report, or other document required to be kept or filed under this act, or any record required to be kept by this act; or  (5) To make, distribute, or possess any punch, die, plate, stone, or other thing designed to print, imprint, or reproduce the trademark, trade name, or other identifying mark, imprint, or device of another or any likeness of any of the foregoing upon any drug or container or labeling thereof so as to render such drug a counterfeit controlled dangerous substance.  b. Any person who violates this section shall be punished by imprisonment for not more than three years, or by a fine of not more than $30,000.00, or both.  L. 1970, c. 226, s. 22; amended by L. 1987, c. 106, s. 18.
NJ Rev Stat § 24:21-23 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-23 - General penalty

24:21-23. General penalty  General Penalty. Any person who violates any provision of this act for which no specific penalty is provided shall be guilty of a disorderly persons offense.  L. 1970, c. 226, s. 23; amended by L. 1987, c. 106, s. 19.
NJ Rev Stat § 24:21-24 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-24 - Attempt, endeavor and conspiracy

24:21-24. Attempt, endeavor and conspiracy  Attempt, endeavor and conspiracy. a. Any person who attempts, endeavors or conspires to commit any offense defined in this act is punishable by imprisonment or fine or both which may not exceed the maximum punishment prescribed for the offense, the commission of which was the object of the endeavor or conspiracy.  b. (Deleted by amendment, P.L. 1987, c. 106.)  L. 1970, c. 226, s. 24; amended by L. 1987, c. 106, s. 20.
NJ Rev Stat § 24:21-25 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-25 - Additional penalties

24:21-25. Additional penalties  Any penalty imposed for violation of this act shall be in addition to, and not in lieu of, any civil or administrative penalty or sanction authorized by law. In any case where a violation of this act is violation of a Federal law or the law of another state, the conviction or acquittal under Federal law or the law of another state for the same act is a bar to prosecution in this State. L.1970, c. 226, s. 25.
NJ Rev Stat § 24:21-29 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-29 - Second or subsequent offenses

24:21-29. Second or subsequent offenses  Second or subsequent offenses. a. Any person convicted of any offense under this act, if the offense is a second or subsequent offense, shall be punished by a term of imprisonment of up to twice that otherwise authorized, by up to twice the fine otherwise authorized, or by both.  b. For purposes of this section, an offense shall be considered a second or subsequent offense, if, prior to the commission of the offense, the offender has at any time been convicted of an offense or offenses under this act or under any law of the United States or of any state relating to narcotic drugs, marihuana, depressant, stimulant, or hallucinogenic drugs.  L. 1970, c. 226, s. 29; amended by L. 1979, c. 388, s. 5; 1987, c. 106, s. 21.
NJ Rev Stat § 24:21-33 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:21-33 - Injunctions

24:21-33. Injunctions  The Superior Court shall have jurisdiction in accordance with the rules of court to enjoin violations of this act. L.1970, c. 226, s. 33.